Many of the identified differentially expressed genes are understudied in glioblastoma; however, several are key regulators of tissue remodeling (MFAP4 and ALX4), mesoderm development (TBX5 and ALX4), and immune modulation (FUT2, C4BPA, MFAP4, and GRM4). This evidence concerns the gene FUT2 and glioblastoma.